Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 699 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q2
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Trade (domestic/foreign), Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
Q2
ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION) for ACADEMY OF NUTRITION AND DIETETICS (FORMERLY AS AMERICAN DIETETIC ASSOCIATION)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Medical/Disease Research/Clinical Labs, Education, Law Enforcement/Crime/Criminal Justice
View →
Q2
GEORGIA INSTITUTE OF TECHNOLOGY for GEORGIA INSTITUTE OF TECHNOLOGY
2nd Quarter (Apr 1 - June 30) 2026 · Georgia · House · Senate
Energy/Nuclear, Medical/Disease Research/Clinical Labs, Science/Technology, Sports/Athletics
View →
Q2
SHIONOGI INC. for SHIONOGI INC.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Insurance, Medicare/Medicaid
View →
Q2
TEXAS CHILDREN'S HOSPITAL for TEXAS CHILDREN'S HOSPITAL
2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q2
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q2
FORBES-TATE for AMGEN USA, INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $50,000.00 income
Taxation/Internal Revenue Code, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q2
FORBES-TATE for CALIFORNIA LIFE SCIENCES ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $40,000.00 income
Manufacturing, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy
View →
Q2
ALSTON & BIRD LLP for THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH
2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $30,000.00 income
Medical/Disease Research/Clinical Labs
View →
1A
UNIVERSITY OF CALIFORNIA for UNIVERSITY OF CALIFORNIA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Agriculture, Budget/Appropriations, Defense, Education
View →
Q2
FORBES-TATE for COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Banking, Financial Institutions/Investments/Securities, Government Issues, Medical/Disease Research/Clinical Labs
View →
Q2
FORBES-TATE for AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $50,000.00 income
Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Health Issues
View →
Q2
UNIVERSITY OF CALIFORNIA for UNIVERSITY OF CALIFORNIA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Immigration, Sports/Athletics, Agriculture
View →
Q2
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER for THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate
Medicare/Medicaid, Budget/Appropriations, Government Issues, Medical/Disease Research/Clinical Labs
View →
Q2
ISEMAN & ASSOCIATES LLC for TICHENOR VENTURES, LLC
2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate
Medical/Disease Research/Clinical Labs, Pharmacy, Aviation/Airlines/Airports, Budget/Appropriations
View →
2T
MICHAEL BEST STRATEGIES LLC for SAREPTA THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
MILLER STRATEGIES, LLC for NEW MOUNTAIN CAPITAL, L.L.C.
2nd Quarter (Apr 1 - June 30) 2026 · New York · $30,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q2
NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC) for SOLVENTUM
2nd Quarter (Apr 1 - June 30) 2026 · Minnesota · House · Senate · $60,000.00 income
Trade (domestic/foreign), Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid
View →
Q2
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate
Health Issues, Insurance, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q2
VANDERBILT UNIVERSITY MEDICAL CENTER for VANDERBILT UNIVERSITY MEDICAL CENTER
2nd Quarter (Apr 1 - June 30) 2026 · Tennessee · House · Senate
Immigration, Veterans, Taxation/Internal Revenue Code, Budget/Appropriations
View →
Q2
DLA PIPER LLP (US) for BIOGEN, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Copyright/Patent/Trademark, Health Issues, Medical/Disease Research/Clinical Labs
View →
Q2
ALSTON & BIRD LLP for BIOMERIEUX, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Utah · House · Senate · $70,000.00 income
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
FORBES-TATE for CAI INVESTMENTS
2nd Quarter (Apr 1 - June 30) 2026 · Nevada · House · Senate · $80,000.00 income
Budget/Appropriations, Chemicals/Chemical Industry, Consumer Issues/Safety/Products, Health Issues
View →
2A
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Medical/Disease Research/Clinical Labs
View →
2A
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Medical/Disease Research/Clinical Labs
View →
Previous Page 2 of 28 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem